xenon radioisotopes has been researched along with substance p in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brain, SD; Cambridge, H | 1 |
| Dockray, GJ; Lamb, G; Taylor, I | 1 |
| Ekman, R; Fahrenkrug, J; Friberg, L; Karle, A; Olesen, J; Olsen, TS | 1 |
| Fan, TP; Gresham, GA; Guard, S; Hu, DE; Watling, KJ | 1 |
4 other study(ies) available for xenon radioisotopes and substance p
| Article | Year |
|---|---|
Calcitonin gene-related peptide increases blood flow and potentiates plasma protein extravasation in the rat knee joint.
Topics: Alprostadil; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Edema; Injections, Intra-Articular; Knee Joint; Male; Rats; Rats, Inbred Strains; Regional Blood Flow; Substance P; Synovial Membrane; Xenon Radioisotopes | 1992 |
Hepatic artery ligation and embolization for the carcinoid syndrome--report of intra-operative liver blood flow studies in a case with high substance P concentration in liver metastases.
Topics: Embolization, Therapeutic; Hepatic Artery; Humans; Intraoperative Period; Ligation; Liver Circulation; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Substance P; Xenon Radioisotopes | 1980 |
Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Topics: Adult; Calcitonin; Calcitonin Gene-Related Peptide; Carotid Artery, Internal; Cerebral Angiography; Cerebrovascular Circulation; Female; Hemiplegia; Humans; Ischemic Attack, Transient; Jugular Veins; Male; Middle Aged; Migraine Disorders; Neuropeptide Y; Neuropeptides; Paresthesia; Radionuclide Imaging; Substance P; Vasoactive Intestinal Peptide; Vision Disorders; Xenon Radioisotopes | 1994 |
Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Indomethacin; Inflammation; Interleukin-1; Male; Neovascularization, Pathologic; Neurokinin-1 Receptor Antagonists; Platelet Activating Factor; Prostaglandins; Rats; Rats, Wistar; Receptors, Interleukin-1; Receptors, Neurokinin-1; Regional Blood Flow; Substance P; Xenon Radioisotopes | 1993 |